RevCycle Intelligence November 1, 2023
Facilities under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) will also see higher Medicare rates for new drugs, according to a final rule.
CMS recently released the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule for 2024, which includes a 2.1 percent Medicare rate hike for renal dialysis services furnished to Medicare beneficiaries after January 1st.
CMS proposed earlier this year to increase Medicare rates for renal dialysis services by just 1.6 percent for a base rate of $269.99. However, the final rule stated that the ESRD PPS base rate for 2024 will increase to $271.02 from $265.57 in the 2023 ESRD PPS final rule.
The dialysis payment for patients with acute kidney industry (AKI) will...
Today's Sponsors
Today's Sponsor